VRPXVirpax Pharmaceuticals, Inc.

Nasdaq virpaxpharma.com


$ 2.16 $ 0.01 (0.45 %)    

Thursday, 02-May-2024 15:43:26 EDT
QQQ $ 435.98 $ 8.58 (2.01 %)
DIA $ 386.87 $ 4.54 (1.19 %)
SPY $ 511.25 $ 6.26 (1.24 %)
TLT $ 89.88 $ 0.90 (1.01 %)
GLD $ 212.97 $ -0.17 (-0.08 %)
$ 2.24
$ 2.41
$ 0.00 x 0
$ 3.38 x 100
$ 2.10 - $ 2.42
$ 2.11 - $ 11.77
7,425
na
2.62M
$ 0.79
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-26-2024 12-31-2023 10-K
2 12-07-2023 09-30-2023 10-Q
3 08-14-2023 06-30-2023 10-Q
4 05-12-2023 03-31-2023 10-Q
5 03-22-2023 12-31-2022 10-K
6 11-09-2022 09-30-2022 10-Q
7 08-15-2022 06-30-2022 10-Q
8 05-16-2022 03-31-2022 10-Q
9 03-31-2022 12-31-2021 10-K
10 11-15-2021 09-30-2021 10-Q
11 08-09-2021 06-30-2021 10-Q
12 05-17-2021 03-31-2021 10-Q
13 03-31-2021 12-31-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 virpax-pharmaceuticals-announced-results-for-a-maximum-tolerated-dose-study-in-sprague-dawley-rats-for-probudur

Probudur is Virpax's injectable long-acting liposomal bupivacaine formulation that is injected at the wound site. Probudur ...

 on-april-2-virpax-pharmaceuticals-inc-got-letter-from-nasdaq-stating-that-company-was-not-in-compliance-with-nasdaq-listing-rule

- SEC Filing

Core News & Articles

As part of the settlement, the parties have agreed to a cash payment from Virpax to the Plaintiffs of $3.5 million by March 1, ...

 virpax-pharmaceuticals-announced-the-initial-results-from-the-pilot-study-for-probudur-performed-by-the-us-army-institute-of-surgical-research-under-an-existing-cooperative-research-and-development-agreement

This study was designed to determine if Probudur reduces pain behaviors in a rat model of incisional pain. Two concentrations o...

 why-quanex-building-products-shares-are-trading-lower-by-over-10-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of Quanex Building Products Corporation (NYSE: NX) moved lower during Friday’s session after the company reported fourth...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION